Leukemia Archives - Oncology Nurse Advisor Wed, 06 Mar 2024 15:39:58 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png Leukemia Archives - Oncology Nurse Advisor 32 32 Chemotherapeutic Conditioning Associated With Lower Rates of Complications in Young Children With ALL https://www.oncologynurseadvisor.com/home/cancer-types/leukemia/acute-leukemia-chemotherapy-condition-lower-rates-children-treatment-risk/ Wed, 06 Mar 2024 14:10:00 +0000 https://www.oncologynurseadvisor.com/?p=116960 Durable Responses Achieved With Venetoclax Plus Obinutuzumab in CLL/SLL https://www.oncologynurseadvisor.com/home/cancer-types/leukemia/cll-sll-leukemia-durable-response-venetoclax-obinutuzumab-treatment-risk/ Tue, 27 Feb 2024 14:05:00 +0000 https://www.oncologynurseadvisor.com/?p=116931 Maternal Exposure to Anticancer Drugs May Increase Risk for Pediatric Leukemia https://www.oncologynurseadvisor.com/home/cancer-types/leukemia/pediatric-cancer-maternal-exposure-anti-cancer-drugs-increase-risk/ Thu, 22 Feb 2024 14:10:00 +0000 https://www.oncologynurseadvisor.com/?p=116828 Relapse Rate Decreased With FLAG-Ida Plus Gemtuzumab Ozogamicin in AML https://www.oncologynurseadvisor.com/home/cancer-types/leukemia/acute-leukemia-aml-relapse-rate-flag-ida-gemtuzumab-ozogamicin-treatment/ Tue, 20 Feb 2024 14:10:00 +0000 https://www.oncologynurseadvisor.com/?p=116708 Obesity Linked to Acute Kidney Injury After HDMTX for Hematologic Cancer https://www.oncologynurseadvisor.com/home/cancer-types/leukemia/obesity-acute-kidney-injury-aki-hdmtx-hematologic-cancer-treatment-risk/ Wed, 07 Feb 2024 16:00:00 +0000 https://www.oncologynurseadvisor.com/?p=116582 Obecabtagene Autoleucel Under Review for Relapsed/Refractory B-Cell ALL https://www.oncologynurseadvisor.com/home/cancer-types/leukemia/obecabtagene-autoleucel-under-review-for-relapsed-refractory-b-cell-all/ Fri, 02 Feb 2024 15:20:00 +0000 https://www.empr.com/?p=214318 Sorafenib Failed to Improve EFS in FLT3-ITD AML https://www.oncologynurseadvisor.com/home/cancer-types/leukemia/acute-leukemia-aml-sorafenib-failed-improve-survival-efs-flt3/ Tue, 30 Jan 2024 15:30:00 +0000 https://www.oncologynurseadvisor.com/?p=116293 Risk for Cancer Increased for Relatives of Patients With Leukemia https://www.oncologynurseadvisor.com/home/cancer-types/leukemia/risk-for-cancer-increased-for-relatives-of-patients-with-leukemia/ Thu, 25 Jan 2024 15:00:00 +0000 https://www.oncologynurseadvisor.com/?p=116118 Venetoclax, Anti-CD20 Monoclonal Antibody Combination Shows Promise in CLL  https://www.oncologynurseadvisor.com/home/cancer-types/leukemia/chronic-leukemia-cll-venetoclax-anti-cd20-monoclonal-antibody-treatment/ Wed, 24 Jan 2024 15:20:00 +0000 https://www.oncologynurseadvisor.com/?p=116173 Midostaurin Plus Chemotherapy Is Well Tolerated in Adults With FLT3-Mutated AML, Irrespective of Age https://www.oncologynurseadvisor.com/home/cancer-types/leukemia/acute-leukemia-aml-midostaurin-chemotherapy-treatment-risk/ Tue, 09 Jan 2024 15:40:00 +0000 https://www.oncologynurseadvisor.com/?p=115914